Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis

FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study

(2020) Philip N Newsome et al.   Lancet Gastroenterology & Hepatology

Magnetic resonance imaging-proton density fat fraction (MRI-PDFF) to predict treatment response on NASH liver biopsy: a secondary analysis of the resmetirom randomized placebo-controlled phase 2 clinical trial

(2020) Rohit Loomba et al.   JOURNAL OF HEPATOLOGY

MRI‐Proton Density Fat Fraction Treatment Response Criteria in Nonalcoholic Steatohepatitis

(2020) Rohit Loomba   HEPATOLOGY

Magnitude‐intrinsic water–fat ambiguity can be resolved with multipeak fat modeling and a multipoint search method

(2019) Alexandre Triay Bagur et al.   MAGNETIC RESONANCE IN MEDICINE

NGM 282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients with Nonalcoholic Steatohepatitis

(2019) Stephen A. Harrison et al.   HEPATOLOGY

GS-06-Positive Results from REGENERATE: A Phase 3 International, Randomized, Placebo-Controlled Study Evaluating Obeticholic Acid Treatment for NASH

(2019) Zobair Younossi et al.   JOURNAL OF HEPATOLOGY

Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver

(2019) Velicia Bachtiar et al.   PLoS One

Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: A proof of concept study

(2019) Christina Levick et al.   PLoS One

Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

(2019) Stephen A Harrison et al.   LANCET

NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances

(2018) Mazen Noureddin et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Alcoholic Liver Disease Replaces Hepatitis C Virus Infection as the Leading Indication for Liver Transplantation in the United States

(2018) George Cholankeril et al.   Clinical Gastroenterology and Hepatology

Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis

(2018) Takeshi Yokoo et al.   RADIOLOGY

Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study

(2018) Natasha McDonald et al.   Scientific Reports

Reference range of liver corrected T1 values in a population at low risk for fatty liver disease—a UK Biobank sub-study, with an appendix of interesting cases

(2018) A. Mojtahed et al.   Abdominal Radiology

Validation of a standardized MRI method for liver fat and T2* quantification

(2018) Chloe Hutton et al.   PLoS One

Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial

(2018) Stephen A. Harrison et al.   PLoS One

Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver disease

(2018) Mustafa R. Bashir et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis

(2017) Michael S. Middleton et al.   GASTROENTEROLOGY

Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease

(2017) Charlie C. Park et al.   GASTROENTEROLOGY

Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity

(2017) Michael Pavlides et al.   LIVER INTERNATIONAL

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

(2017) Zobair Younossi et al.   Nature Reviews Gastroenterology & Hepatology

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice

(2016) Parambir S. Dulai et al.   JOURNAL OF HEPATOLOGY

Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease

(2016) Michael Pavlides et al.   JOURNAL OF HEPATOLOGY

Influence of fat on liverT1measurements using modified Look-Locker inversion recovery (MOLLI) methods at 3T

(2016) Ferenc E. Mozes et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

A model for hepatic fibrosis: the competing effects of cell loss and iron on shortened modified Look-Locker inversion recoveryT1(shMOLLI-T1) in the liver

(2016) Elizabeth M. Tunnicliffe et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis

(2016) Janki Patel et al.   Therapeutic Advances in Gastroenterology

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2015) Paul Angulo et al.   GASTROENTEROLOGY

Ezetimibe for the treatment of nonalcoholic steatohepatitis: Assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)

(2015) Rohit Loomba et al.   HEPATOLOGY

Accuracy of MR Imaging–estimated Proton Density Fat Fraction for Classification of Dichotomized Histologic Steatosis Grades in Nonalcoholic Fatty Liver Disease

(2015) An Tang et al.   RADIOLOGY

Inter-observer and Intra-observer Agreement in Pathological Evaluation of Non-alcoholic Fatty Liver Disease Suspected Liver Biopsies

(2014) Omid Pournik et al.   Hepatitis Monthly

Pathophysiology of NASH: Perspectives for a Targeted Treatment

(2013) Fabio Marra et al.   CURRENT PHARMACEUTICAL DESIGN

Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials

(2013) Mazen Noureddin et al.   HEPATOLOGY

Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease

(2013) Rajarshi Banerjee et al.   JOURNAL OF HEPATOLOGY

From NAFLD to NASH to cirrhosis—new insights into disease mechanisms

(2013) Alexander Wree et al.   Nature Reviews Gastroenterology & Hepatology

Nonalcoholic Fatty Liver Disease: MR Imaging of Liver Proton Density Fat Fraction to Assess Hepatic Steatosis

(2013) An Tang et al.   RADIOLOGY

Hepatic Steatosis: Quantification by Proton Density Fat Fraction with MR Imaging versus Liver Biopsy

(2013) Ilkay S. Idilman et al.   RADIOLOGY

Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD

(2012) Z. Permutt et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients

(2012) Pierre Bedossa et al.   HEPATOLOGY

Nonalcoholic Fatty Liver Disease: Pathologic Patterns and Biopsy Evaluation in Clinical Research

(2012) David Kleiner et al.   SEMINARS IN LIVER DISEASE

Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms

(2011) Geraldine H. Kang et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING